EMA extends scientific advice pilot for high-risk medical devices

BY COREY JASEPH, MS, RAC

This week, the European Medicines Agency announced plans to extend the call for participation in its scientific advice pilot program, which is directed at helping manufacturers develop their clinical programs for high-risk medical devices. Although the agency originally intended to select all projects by the end of 2023, the application window for this unplanned third phase will close in June.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap